Pyc Therapeutics Ltd has released a press release.
Phylogica Strategic Update - Pivot to Platform
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Quarterly Update and Appendix 4C
- PYC Granted US Patent for Peptides Entering Brain Cells
- New Delivery Vehicles Show Improved Performance Inside Cells
- Appendix 4E - Preliminary Final Report 30 June 2017
- Response to ASX Query
Later from PYC Therapeutics
- FPP Results Effective in Delivering Peptide Cancer Vaccine
- Federal R&D Tax Credit Received
- Dec Quarterly Update and Appendix 4C
- Dec 2017 Half-year financial statements & Appendix 4D
- Cre Enzyme Delivery Provides Validation & Strategic Value
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics